MENU
+Compare
BIVI
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.48
Change
-$0.15 (-9.20%)
Capitalization
27.4M

BIVI BioVie Inc Forecast, Technical & Fundamental Analysis

Industry Biotechnology
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BIVI with price predictions
Feb 21, 2025

BIVI sees MACD Histogram just turned negative

BIVI saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 21, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 41 instances where the indicator turned negative. In of the 41 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BIVI as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIVI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BIVI entered a downward trend on February 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for BIVI's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BIVI advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

BIVI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.145) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). BIVI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.218).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BIVI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIVI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BIVI is expected to report earnings to fall 25.00% to -15 cents per share on August 28

BioVie Inc BIVI Stock Earnings Reports
Q2'24
Est.
$-0.15
Q1'24
Est.
$-0.20
Q4'23
Est.
$-0.23
Q3'23
Est.
$-0.29
Q2'23
Est.
$-0.25
The last earnings report on May 10 showed earnings per share of -20 cents, meeting the estimate of -20 cents. With 598.17K shares outstanding, the current market capitalization sits at 27.40M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
680 W Nye Lane
Phone
+1 775 888-3162
Employees
13
Web
https://www.bioviepharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRIS3.10N/A
N/A
Curis
PBFS11.75N/A
N/A
Pioneer Bancorp
GOLD18.30-0.52
-2.76%
Barrick Gold Corp
BOX33.47-1.21
-3.49%
BOX
RCKT10.47-0.40
-3.68%
Rocket Pharmaceuticals

BIVI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BIVI has been loosely correlated with HOFBF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BIVI jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIVI
1D Price
Change %
BIVI100%
-9.20%
HOFBF - BIVI
44%
Loosely correlated
N/A
HURA - BIVI
42%
Loosely correlated
+0.91%
SCNI - BIVI
34%
Loosely correlated
+4.28%
BIORQ - BIVI
33%
Loosely correlated
-2.04%
ITOS - BIVI
27%
Poorly correlated
-0.94%
More